Navigation Links
A Breakthrough for Migraines, PMS and PCOS!
Date:12/23/2010

LOS ANGELES, Dec. 23, 2010 /PRNewswire/ -- In a world where millions suffer daily from the debilitating pain of migraine headaches, one name stands out as the definitive leader in natural, safe and effective treatment.  MigreLief by Akeso Health Sciences.

Now, patients are raving about the amazing results of the new breakthrough product from Akeso.  MigreLief+M (Menstrual) is the first of its kind supplement aimed at preventing migraines and other symptoms associated with a woman's menstrual cycle.

"There is a direct relationship between hormones and headaches," explains Curt Hendrix M.S. C.C.N., C.N.S., scientist and creator of MigreLief+M. "Headaches in women, particularly migraines, have been related to changes in the levels of the female hormones estrogen and progesterone before, during and after a woman's menstrual cycle.  These hormone levels fluctuate dramatically and are associated with a large percentage of migraines in women."

The release of MigreLief+M is life-changing news, not only for migraine sufferers but also for women who experience PMS symptoms such as cravings, breast tenderness, bloating, cramps, depression and irritability.  The active ingredients in this menstrually targeted MigreLief have been shown to not only balance the hormonal fluctuations that lead to menstrual related migraines, but also significantly decrease PMS symptoms as well.

What is the secret to the success of world renowned MigreLief? "The ingredients that are used are continuously monitored for quality and integrity by independent analytical laboratories throughout the manufacturing process. These ingredients are then used in the exact form and dose proven effective in human clinical studies.  Our supplements are of higher quality than those currently on the market because of this exacting scientific attention to purity and potency."

MigreLief+M is no exception and promises to be another winner with a multitude of added benefits:

  • Same reliable migraine treatment as MigreLief original formula with additional compounds to treat Menstrual migraines and alleviate many PMS and PCOS symptoms.
  • May be beneficial in reducing the occurrence of premenstrual acne.
  • Can be taken with your prescription migraine drugs and has no side-effects.
  • Regulates blood sugar balance that is a migraine trigger in many patients.
  • MigreLief Facebook and Twitter interface directly with consumers to support their ongoing health questions and needs.

  • All MigreLief products are available in select pharmacies and online at www.migrelief.com.  For more information and product samples contact sales@akesohealth.com.  

    About Akeso Health SciencesFounded by Curt Hendrix in 1992, Akeso is a family company dedicated to continuing research and breakthrough technologies for the development of patented supplements that have helped tens of thousands find the joy and peace of a new life without migraines.  The company consistently delivers innovative, leading edge solutions for migraineurs worldwide. (www.migrelief.com)Contact:Steve Hendrixsales@akesohealth.com (800) 758-8746DISCLAIMER: MigreLief™ is not intended to diagnose, treat, cure, or prevent any disease or illness.  Frequent use of this product may result in considerable weight loss.  Please consult with your licensed medical practitioner if you have, or suspect you may have, a health problem.


    '/>"/>

    SOURCE Akeso Health Sciences
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Bad Virus Put to Good Use: Breakthrough Batteries
    2. Bridging between Earth and space: technology breakthroughs for scientific progress
    3. Breakthrough in nanocrystals growth
    4. A revolutionary breakthrough in terahertz remote sensing
    5. European Nurse Society Calls to Action on Breakthrough Cancer Pain
    6. Breakthrough e-display means electronics with high speed, high readability and low power usage
    7. Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs and files two PCT patent applications
    8. Deloitte Recap Honors Sanofi-aventis and Exelixis With the Allicense 2010 Breakthrough Alliance Award for Early-Stage Collaboration in Cancer
    9. Breakthrough gene therapy prevents retinal degeneration
    10. New paper offers breakthrough on blinking molecules phenomenon
    11. A revolutionary breakthrough in terahertz remote sensing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/10/2016)... ... February 10, 2016 , ... Global Stem Cells ... with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical ... the latest adipose and bone marrow therapies. , Through the new collaboration, ...
    (Date:2/9/2016)... FALLS, N.J. , Feb. 9, 2016 /PRNewswire/ ... a biotechnology company specializing in the development and ... health of damaged tissues and organs, recently reported ... for the first quarter of 2016. ... began the new 2015 fiscal year in the ...
    (Date:2/9/2016)... ... February 09, 2016 , ... Tunnell Consulting, Inc. announced that Frédéric ... he will focus on acquiring new accounts and work closely with existing Tunnell clients ... “Fred brings to our European clients more than 15 years of experience in the ...
    (Date:2/9/2016)... 2016  DNAtrix, a clinical stage, biotechnology ... that its lead product, DNX-2401, has been ... orphan medicinal product for the treatment of ... strikes approximately 25,000 people a year in ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
    Breaking Biology Technology:
    (Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
    (Date:1/25/2016)... Software, the world-leading supplier of image data management solutions ... data management solution OMERO Plus for the newly established ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... analysis measures the characteristics and behavior of cells, tissues ... as health and disease, the presence or absence of ...
    (Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
    Breaking Biology News(10 mins):